1382
Helvetica Chimica Acta – Vol. 90 (2007)
112.6; 109.6; 66.3; 65.8; 61.6; 61.5; 14.1. MS: 416 (11.8, Mþ), 329 (3.4), 287 (13.4), 255 (4.9), 204 (10), 149
(10) 69 (100). Anal. calc. for C21H20O7S (416.44): C 60.57, H 4.84; found: C 60.68, H 4.77.
Diethyl 2,2’-[(9-Oxo-9H-thioxanthene-1,2-diyl)bis(oxy)]bis[acetate] (6). As described for 5, with
K2CO3 (5 g), acetone (200 ml), 4 (2.5 g, 0.01 mol), and ethyl bromoacetate (4 ml, 0.024 mol), for 24 h
under reflux. The yellow solid was subjected to CC (silica gel, CHCl3/hexane): 6 (2.1 g, 60%). Yellow
solid. M.p. 104 – 1058. IR(KBr): 1750 s, 1723s, 1630s, 1590s, 1504s, 1430s, 1145s. 1H-NMR(CDCl
,
3
250 MHz): 8.31 (d, J ¼ 7.6, 1 H); 7.32 – 7.45 (m, 5 H); 4.79 (s, 2 H); 4.68 (s, 2 H); 4.27 (q, J ¼ 7.1, 2 H); 4.16
(q, J ¼ 7.1, 2 H); 1.25 (t, J ¼ 7.1, 3 H); 1.19 (t, J ¼ 7.1, 3 H ) . 13C-NMR(CDCl 3, 62.9 MHz): 180.4; 169.1;
168.7; 150.0; 149.9; 135.7; 131.8; 130.9; 129.6; 126.2; 125.1; 122.2; 121.7; 70.2; 67.5; 61.3; 60.9; 14.2; 14.1.
MS: 416 (11.8, Mþ), 329 (3.4), 287 (13.4), 255 (4.9), 204 (10), 149 (10) 69 (100). Anal. calc. for C21H20O7S
(416.44): C 60.57, H 4.84; found: C 60.65, H 4.73.
5,6,7,8,9,10-Hexahydro-2H,20H-thioxantheno[2,3-b] [1,4,7,10,13]dioxatriazacyclopentadecine-
3,11,20(4H,12H)-trione (7). To a soln. of 5 (1.5 g, 0.0036 mol) in EtOH (400 ml) was added N1-(2-
aminoethyl)ethane-1,2-diamine (0.4 ml 0.0038 mol), and the mixture was left overnight at 508. After this
time, the precipitate was collected by filtration: 7 (1.1 g, 70%). M.p. > 3008. IR(KBr): 3396 (br.), 1690 s,
1
1595s, 1542s, 1504s, 1259s, 1143s, 750s. H-NMR((D )DMSO, 250 MHz): 8.43 (d, J ¼ 7.6, 1 H); 7.87 (s,
6
1 H); 7.69 – 7.88 (m, 4 H); 7.55 (t, J ¼ 7.0, 1 H); 7.46 (s, 1 H); 4.65 (s, 4 H); 2.73 (s, 3 H); 2.48 (s, 4 H).
13C-NMR(CDCl 3, 62.9 MHz): 177.7; 166.2; 165.9; 152.7; 146.2; 136.4; 129.8; 128.0; 126.8; 117.8; 112.1;
67.8; 50.7; 35.1. MS: 428 (0.8, [M þ 1]þ), 427 (5.4, Mþ), 384 (4.2), 359 (28.7), 285 (49.0), 257 (38.7), 228
(16.1), 171 (25.7%), 56 (100). Anal. calc. for C21H21N3O5S (427.47): C 59.00, H 4.95; found: C 59.36, H
4.86.
5,6,7,8,9,10-Hexahydro-2H,21H-thioxantheno[1,2-b] [1,4,7,10,13]dioxatriazacyclopentadecine-
3,11,21(4H,12H)-trione (8). As described for 7, with 6 (1.5 g, 0.0036 mol), EtOH (200 ml), and N1-(2-
aminoethyl)ethane-1,2-diamine (0.4 ml, 0.0038 mol) for 48 h. The mixture was concentrated and the
yellow solid subjected to CC (silica gel, EtOH/AcOEt): 8 (0.9 g, 60%). Yellow solid. M.p. 232 – 2348. IR
(KBr): 3393 (br.), 1685s, 1592s, 1540s, 1514s, 1250s, 1133s, 752s. 1H-NMR(CDCl 3, 250 MHz): 8.44 (d, J ¼
8.0, 1 H); 7.69 (s, 2 H); 7.44 – 7.58 (m, 3 H); 7.38 (d, J ¼ 8.9, 1 H); 7.22 (d, J ¼ 8.9, 1 H); 4.61 (s, 2 H); 4.50
(s, 2 H); 3.49 – 3.56 (m, 2 H); 3.41 – 3.47 (m, 2 H); 2.86 – 2.90 (m, 4 H); 1.64 (s, 1 H). 13C-NMR(CDCl 3,
62.9 MHz): 168.7; 166.4; 157.0; 148.5; 142.0; 136.0; 132.2; 130.0; 129.7; 126.4; 125.4; 122.9; 117.7; 72.1;
67.5; 46.4; 45.7; 37.8; 37.2. MS: 427 (25.0, Mþ), 384 (4.2), 359 (26.9), 285 (51.3), 257 (32.3), 228 (23.1), 171
(35.7), 56 (100). Anal. calc. for C21H21N3O5S (427.47): C 59.00, H 4.95; found: C 59.38, H 4.87.
Thioxanthenone-FusedAzacrown Ethers 9 – 11: General Procedure. Azacrown ether 7 (1 mmol), a
phenol 8 (2 mmol), paraformaldehyde (2 mmol), and silica gel (1 g) were thoroughly mixed. The
resulting fine powder was transferred to a round-bottom flask and stirred in an oil bath at 1208 for 2 h.
After cooling, CHCl3 (3 ꢁ 25 ml) was added, and the silica gel was removed by filtration. Evaporation of
the solvent gave the crude product in 50 – 70% yield, which was purified by CC (EtOH/AcOEt).
7-[5-(tert-Butyl)-2-hydroxybenzyl]-5,6,7,8,9,10-hexahydro-2H,20H-thioxantheno[2,3-b] [1,4,7,
10,13]dioxatriazacyclopentadecine-3,11,20(4H,12H)-trione (9): M.p. 248 – 2508. IR(KBr): 3371 (br.),
1
2956s, 1670s, 1596s, 1437s, 1209s, 825s, 750s. H-NMR(CDCl 3, 250 MHz): 8.46 (d, J ¼ 6.9, 1 H); 7.94 (s,
1 H); 7.85 (s, 1 H); 7.77 (s, 1 H); 7.39 – 7.46 (m, 3 H); 7.24 (dd, 3J ¼ 8.4, 4J ¼ 2.4, 1 H); 7.20 (s, 1 H); 7.00 (d,
J ¼ 8.4, 1 H); 6.59 (s, 1 H); 4.68 (s, 2 H); 4.14 (s, 2 H); 3.80 (s, 2 H); 3.48 (s, 4 H); 2.77 (s, 4 H); 1.30 (s,
12 H). 13C-NMR(CDCl 3, 62.9 MHz): 177.3; 166.2; 165.9; 154.7; 150.9; 147.3; 146.2; 136.4; 132.2; 131.9;
131.4; 130.2; 128.8; 127.7; 127.3; 126.6; 126.3; 122.8; 116.5; 112.0; 67.5; 52.1; 49.3; 36.8; 32.0; 29.7. MS: 427
(13.4, [M ꢀ 163]þ), 359 (45.7), 285 (49.6), 147 (100), 73 (37). Anal. calc. for C32H32N3O6S (589.70): C
65.18, H 5.98; found: C 65.46, H 5.86.
5,6,7,8,9,10-Hexahydro-7-(2-hydroxy-5-methylbenzyl)-2H,20H-thioxantheno[2,3-b][1,4,7,10,13]di-
oxatriazacyclopentadecine-3,11,20(4H,12H)-trione (10): M.p. 256 – 2588. IR(KBr): 3382 (br.), 2950 s,
1662s, 1588s, 1430s, 1215s, 829s, 740s. 1H-NMR(CDCl 3, 250 MHz): 9.19 (s, 1 H); 8.41 (d, J ¼ 7.9, 1 H); 7.88
(s, 1 H); 7.51 – 7.84 (m, 5 H); 7.46 (s, 1 H); 6.97 (s, 1 H); 6.75 (d, J ¼ 8.0, 1 H); 6.57 (d, J ¼ 8.0, 1 H); 4.57 (s,
4 H); 3.77 (s, 2 H); 2.63 (s, 8 H); 1.99 (s, 3 H). 13C-NMR(CDCl 3, 62.9 MHz): 177.4; 166.3; 165.9; 154.7;
150.9; 146.2; 136.5; 132.4; 132.1; 131.4; 130.1; 128.8; 127.7; 127.2; 126.5; 122.6; 116.8; 112.0; 67.6; 52.3;
49.3; 19.7. MS: 359 (21.4, [M ꢀ 188]þ), 285 (33.9), 284 (16.1), 257 (26.8), 171 (16.1), 139 (12.5), 56 (100).
Anal. calc. for C29H29N3O6S (547.62): C 63.60, H 5.34; found: C 65.34, H 5.46.